Institutional Investor

With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma With the broader IPO calendar still muted, biopharma and life sciences issuers are cautiously testing the waters — and early trading in one name is giving the sector a modest tailwind. So far, just si...

As January IPO activity remains low, biopharma and life sciences companies are tentatively navigating public offerings, with six firms already listing shares in 2026, including Aktis Oncology which raised $318 million.
www.institutionalinvestor.com/article/thin...

Facing Anemic Returns, Allocators Struggle to Reach 8% Hurdle With industry practitioners uniformly forecasting mediocre public and private market returns for the foreseeable future, institutional investors are left struggling to achieve the sufficient returns n...

The largest money managers forecast U.S. equity returns below 6% for the next 10-20 years, compelling institutional investors, especially endowments, to seek creative solutions to meet their 8% return hurdle. www.institutionalinvestor.com/article/faci...

Bearish but Booming, David Einhorn’s Greenlight Starts 2026 With a Win Greenlight Capital had a strong start to the new year, posting a 2.7 percent gain in January.This is especially impressive given that the long-short firm, which has been bearish on the stock market fo...

Greenlight Capital reported a 2.7% gain in January, notable considering its continuing bearish outlook on U.S. equities, described as the most expensive in history. This suggests a dynamic approach for asset managers navigating market challenges.
www.institutionalinvestor.com/article/prem...

Kuwait’s ‘Wealth Engineers’ Seek Defensive Growth Amid Volatility Some of the most influential investors in the Gulf country of Kuwait are taking a defensive approach to portfolio management this year amid growing geopolitical tensions in the region and further afie...

Kuwait’s Action Group Holdings underscores the significance of defensive portfolio management as geopolitical tensions rise. Their responsible governance aims to preserve capital amid potential market volatility for the ruling family’s assets. www.institutionalinvestor.com/article/kuwa...

Secondaries Behind Family Office Charge to Private Equity J.P. Morgan Private Bank’s 2026 Global Family Office Report has found that 37 percent of respondents expect to raise allocations to private equity in the next year and a half.

J.P. Morgan’s 2026 Global Family Office Report reveals that 37% of family offices plan to increase their allocations to private equity over the next 18 months, indicating a shift in portfolio strategies. www.institutionalinvestor.com/article/seco...

Abu Dhabi Moves to Become the Gulf’s Private Credit Capital Abu Dhabi is no longer just a source of capital for U.S. and European private credit managers. The emirate is building a financial hub and private credit ecosystem where deals are originated, structur...

Abu Dhabi's private credit market, projected to grow from $5 billion in 2024 to $11-$20 billion by 2030, is witnessing a surge in local deal origination, driven by sovereign investors like Mubadala and ADIA. www.institutionalinvestor.com/article/abu-...

The Tiger Grandcub Who Outsmarted the AI Frenzy Jay Kahn’s Flight Deck Capital had its first breakout year since its 2021 founding. Last year, the Tiger Grandcub and onetime Institutional Investor Hedge Fund Rising Star saw a 51.6 percent jump in t...

Jay Kahn’s Flight Deck Capital achieved a 51.6% return in his long-short TMT hedge fund, emphasizing investments in technology 'enablers' rather than high-profile firms. This strategy simultaneously challenges traditional funding approaches. www.institutionalinvestor.com/article/tige...

Liquidity Isn’t the Problem You Think It Is, Says Ludovic Phalippou Despite beliefs to the contrary, liquidity is not a pressing concern for private equity investors, according to Ludovic Phalippou, the University of Oxford Said Business School professor.

Ludovic Phalippou of Oxford argues that liquidity isn't the primary issue for private equity investors. Instead, a misbalance in capital commitments must be addressed, as it may lead investors to over-commit as allocations fluctuate. www.institutionalinvestor.com/article/liqu...

With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma With the broader IPO calendar still muted, biopharma and life sciences issuers are cautiously testing the waters — and early trading in one name is giving the sector a modest tailwind. So far, just si...

In a muted IPO market, just six companies have gone public this January, with biopharma issuers like Aktis Oncology raising $318 million. Hedge funds are capitalizing on this trend, indicating a shift in their focus to life sciences.
www.institutionalinvestor.com/article/thin...

Facing Anemic Returns, Allocators Struggle to Reach 8% Hurdle With industry practitioners uniformly forecasting mediocre public and private market returns for the foreseeable future, institutional investors are left struggling to achieve the sufficient returns n...

The largest money managers project U.S. equity returns to be below 6% over the next 10 to 20 years, compelling allocators, particularly endowments and foundations, to rethink their strategies to meet an 8% return threshold. www.institutionalinvestor.com/article/faci...

How Hiddenite, a Young Long‑Short Fund, Delivered a Second Straight Triple‑Digit Year Hiddenite Capital Partners capped off its second consecutive year of triple digit gains in 2025, delivering a 102 percent net return despite a weak finish to the year. The long-short fund, headed by R...

Hiddenite Capital Partners achieved a 102% net return in 2025, following a nearly 120% surge in 2024. This performance showcases the effective approach of focusing on concentrated equity positions combined with options in challenging market conditions.
www.institutionalinvestor.com/article/how-...

Not All Endowments and Foundations Are All-In on AI While AI continues to eat up the bulk of investor capital, some allocators — particularly endowments and foundations — are beginning to slow their roll and look outside the boom for opportunities.

Despite global AI spending projected to rise 44% to $2.52 trillion, allocators like the Doris Duke Foundation are reconsidering their strategies, seeking opportunities beyond the AI boom to mitigate risks related to inflated valuations. www.institutionalinvestor.com/article/not-...

Kuwait’s ‘Wealth Engineers’ Seek Defensive Growth Amid Volatility Some of the most influential investors in the Gulf country of Kuwait are taking a defensive approach to portfolio management this year amid growing geopolitical tensions in the region and further afie...

As Kuwait's geopolitical tensions rise, CIO Asif Khan sees the need for a proactive, defensive management strategy, focusing on thorough due diligence. This approach reflects a broader trend among the country’s major investors. www.institutionalinvestor.com/article/kuwa...

Two Years In, Doha’s Venture Capital Gambit Gains Another Backer A seventh venture capital firm has joined the Qatar Investment Authority’s ambitious fund-of-funds program, signaling that the initiative is gaining traction with its two-pronged mandate. Silicon Vall...

Founders Circle Capital has joined Qatar Investment Authority’s fund-of-funds program, investing over $500 million in VC initiatives. This growth reflects increasing interest from regional and international firms looking to scale and innovate in Qatar. www.institutionalinvestor.com/article/two-...

Abu Dhabi Moves to Become the Gulf’s Private Credit Capital Abu Dhabi is no longer just a source of capital for U.S. and European private credit managers. The emirate is building a financial hub and private credit ecosystem where deals are originated, structur...

PwC predicts a robust growth in the private credit market within the Gulf Cooperation Council and Egypt, potentially rising from $5 billion in 2024 to up to $20 billion by 2030. Underscoring Abu Dhabi's ambitions to evolve its financial ecosystem.
www.institutionalinvestor.com/article/abu-...

The Tiger Grandcub Who Outsmarted the AI Frenzy Jay Kahn’s Flight Deck Capital had its first breakout year since its 2021 founding. Last year, the Tiger Grandcub and onetime Institutional Investor Hedge Fund Rising Star saw a 51.6 percent jump in t...

Flight Deck Capital's Jay Kahn achieved a 51.6% return last year, focusing on AI enablers rather than high-profile companies. This strategy positions the fund positively amid evolving tech investments, managing close to $300 million. www.institutionalinvestor.com/article/tige...

Liquidity Isn’t the Problem You Think It Is, Says Ludovic Phalippou Despite beliefs to the contrary, liquidity is not a pressing concern for private equity investors, according to Ludovic Phalippou, the University of Oxford Said Business School professor.

Ludovic Phalippou argues that liquidity is not a significant issue for PE investors with a balanced portfolio. He suggests focusing on capital commitment instead. This perspective may prompt institutional allocators to rethink their portfolio strategies.
www.institutionalinvestor.com/article/liqu...

Facing Anemic Returns, Allocators Struggle to Reach 8% Hurdle With industry practitioners uniformly forecasting mediocre public and private market returns for the foreseeable future, institutional investors are left struggling to achieve the sufficient returns n...

The largest money managers project U.S. equity returns to fall below 6% over the next 10-20 years, compelling allocators to devise unique strategies to meet the 8% return necessary for their spending rates. www.institutionalinvestor.com/article/faci...

With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma With the broader IPO calendar still muted, biopharma and life sciences issuers are cautiously testing the waters — and early trading in one name is giving the sector a modest tailwind. So far, just si...

January saw only six IPOs, but Aktis Oncology's success has provided a reference point for biopharma companies pursuing public offerings. Hedge funds are actively participating, indicating potential shifts for future market participants.
www.institutionalinvestor.com/article/thin...

How Hiddenite, a Young Long‑Short Fund, Delivered a Second Straight Triple‑Digit Year Hiddenite Capital Partners capped off its second consecutive year of triple digit gains in 2025, delivering a 102 percent net return despite a weak finish to the year. The long-short fund, headed by R...

Hiddenite Capital Partners achieved a 102% net return in 2025, with 70% of gains sourced from equities. The long-short fund's strong performance underscores its effective strategy for institutional investors.
www.institutionalinvestor.com/article/how-...

Kuwait’s ‘Wealth Engineers’ Seek Defensive Growth Amid Volatility Some of the most influential investors in the Gulf country of Kuwait are taking a defensive approach to portfolio management this year amid growing geopolitical tensions in the region and further afie...

Kuwait’s top investors, including Action Group Holdings, are adopting defensive portfolio strategies amidst rising geopolitical tensions in the region. This shift emphasizes the need for rigorous due diligence practices to mitigate risks. www.institutionalinvestor.com/article/kuwa...

Not All Endowments and Foundations Are All-In on AI While AI continues to eat up the bulk of investor capital, some allocators — particularly endowments and foundations — are beginning to slow their roll and look outside the boom for opportunities.

Even as global AI spending is projected to rise 44% this year to $2.52 trillion, concerns about stratospheric valuations lead some endowments to seek opportunities beyond AI, focusing on under-explored sectors.
www.institutionalinvestor.com/article/not-...

Kuwait’s ‘Wealth Engineers’ Seek Defensive Growth Amid Volatility Some of the most influential investors in the Gulf country of Kuwait are taking a defensive approach to portfolio management this year amid growing geopolitical tensions in the region and further afie...

Kuwait’s top investors, including Action Group Holdings, are adopting defensive portfolio strategies amidst rising geopolitical tensions in the region. This shift emphasizes the need for rigorous due diligence practices to mitigate risks. www.institutionalinvestor.com/article/kuwa...

Two Years In, Doha’s Venture Capital Gambit Gains Another Backer A seventh venture capital firm has joined the Qatar Investment Authority’s ambitious fund-of-funds program, signaling that the initiative is gaining traction with its two-pronged mandate. Silicon Vall...

With the addition of Founders Circle Capital, the Qatar Investment Authority’s fund-of-funds program has now attracted seven firms. Signaling a rising interest from both regional and international investors aiming to tap into the Qatari and Gulf markets. www.institutionalinvestor.com/article/two-...

The Tiger Grandcub Who Outsmarted the AI Frenzy Jay Kahn’s Flight Deck Capital had its first breakout year since its 2021 founding. Last year, the Tiger Grandcub and onetime Institutional Investor Hedge Fund Rising Star saw a 51.6 percent jump in t...

Jay Kahn’s Flight Deck Capital achieved a 51.6% increase in his long-short TMT hedge fund in a year when prominent players focused on Nvidia. This demonstrates strong management amid a volatile tech sector, relevant for institutional investors.
www.institutionalinvestor.com/article/tige...

Liquidity Isn’t the Problem You Think It Is, Says Ludovic Phalippou Despite beliefs to the contrary, liquidity is not a pressing concern for private equity investors, according to Ludovic Phalippou, the University of Oxford Said Business School professor.

Ludovic Phalippou of Oxford reveals that liquidity is not a primary concern for private equity investors when maintaining a balanced portfolio. This perspective could reshape strategies for institutional allocators. www.institutionalinvestor.com/article/liqu...

How Hiddenite, a Young Long‑Short Fund, Delivered a Second Straight Triple‑Digit Year Hiddenite Capital Partners capped off its second consecutive year of triple digit gains in 2025, delivering a 102 percent net return despite a weak finish to the year. The long-short fund, headed by R...

Hiddenite Capital Partners achieved a 102 percent net return in 2025, sustaining strong performance with $400 million under management. This dual success adds pressure on asset managers to revisit their portfolio strategies. www.institutionalinvestor.com/article/how-...

The Lowdown on High Ground’s Best Year High Ground Investment Management capped its strongest year ever with a 3.57 gain in December, according to the firm’s December report, obtained by Institutional Investor. It finished up 39.41 percent...

High Ground Investment Management achieved a remarkable 39.41% annual gain, significantly outpacing the market in 2025. This performance underscores the shifting dynamics in Europe-focused hedge funds. www.institutionalinvestor.com/article/prem...

Two Years In, Doha’s Venture Capital Gambit Gains Another Backer A seventh venture capital firm has joined the Qatar Investment Authority’s ambitious fund-of-funds program, signaling that the initiative is gaining traction with its two-pronged mandate. Silicon Vall...

Qatar Investment Authority’s $1 billion fund-of-funds gains momentum with the addition of Founders Circle Capital, a Silicon Valley VC firm. This shift reflects growing international interest in the Qatari startup ecosystem. www.institutionalinvestor.com/article/two-...

This Foundation Invests Almost Everything in Private Equity and VC. How Does It Work? While most endowments and foundations are working to ensure they have ample liquidity, The Dietrich Foundation is taking the opposite approach. Roughly 90 percent of its $1.6 billion portfolio is allo...

The Dietrich Foundation allocates roughly 90 percent of its $1.6 billion portfolio to venture capital and private equity, limiting cash to just 2 percent, showcasing an unconventional investment strategy designed to maximize growth.
www.institutionalinvestor.com/article/foun...